Global ePharmacy
Global ePharmacy

ePharmacy Comprehensive Study by Type (Skin Care, Dental, Cold and Flu, Vitamins, Weight Loss, Other), Drug Type (Prescription Drugs, Over-The-Counter (OTC) Drugs), Mode of Use (Mobile Applications, Webpage Based) Players and Region - Asia Pacific Market Outlook to 2024

ePharmacy Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Jul 2019 Edition 204 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Scope of the Study
Today we witness a phase transition of buying pattern of any goods, clothes, electronics, furniture, grocery, etc. With the initiation of new technology, offline shopping switches to online mode. Buying anything online is in trends. Buying drugs or medicines online is the latest trend amongst patients and consumers. With this growing trend of buying medicines online, the number of online pharmacies also increase. However, there is a lack of proper regulatory forms and balances for exercising regulatory control over e-pharmacies. There are some other aspects which also fuel the gearing up of e-pharmacies such as increased number of netizens, long term illness patients and increased chronic diseases.

The market study is being classified by Type (Skin Care, Dental, Cold and Flu, Vitamins, Weight Loss and Other) and major geographies with country level break-up.

Netmeds.com (India), 1mg (India), Apollo Pharmacy (India), BestKenko (Japan), Healthkart (India), PharmEasy (India), ePharmacy.com.au (Australia), MyraMed (India), Pharmacy Online (Australia) and Metapharmacy.in (India) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Medplusmart (India), mChemist (India), Medidart.com (India) and MedsonWay (India).

Leading key players are focusing on area expansion to improve their sells and also focusing on increasing their client base to strengthen market position and to enhance product & service offerings. Research Analyst at AMA predicts that Indian Players will contribute to the maximum growth of Asia Pacific ePharmacy market throughout the predicted period.

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Asia Pacific ePharmacy market by Type, Application and Region.

On the basis of geography, the market of ePharmacy has been segmented into Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific). If we see Market by Drug Type, the sub-segment i.e. Prescription Drugs will boost the ePharmacy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Mode of Use, the sub-segment i.e. Mobile Applications will boost the ePharmacy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increase in the Number of Internet Consumers
  • Improved Access to Web-based and Online Services
  • Growing Implementation of E-prescriptions in Hospitals and Other Healthcare Services

Market Trend
  • Increasing Demand for Healthcare Products & Services

Restraints
  • Rising Number of Illegal Online Pharmacies

Opportunities
  • Rising Number of Illegal Online Pharmacies

Challenges
  • Regulatory Hurdles Related to ePharmacy
  • Lack of Cold Chain Logistic Services



The Central Drugs Standard Control Organisation (CDSCO), which regulates pharmaceuticals and medical devices in India, and the Ministry of Health and Family Welfare are currently working towards framing a policy for regulating online pharmacies.

Key Target Audience
ePharmacy Companies, Suppliers of Drugs, Online Service Providers, Healthcare Industry, Governmental Bodies, Regulatory Bodies and Research Firms

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Skin Care
  • Dental
  • Cold and Flu
  • Vitamins
  • Weight Loss
  • Other
By Drug Type
  • Prescription Drugs
  • Over-The-Counter (OTC) Drugs

By Mode of Use
  • Mobile Applications
  • Webpage Based

By Regions
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in the Number of Internet Consumers
      • 3.2.2. Improved Access to Web-based and Online Services
      • 3.2.3. Growing Implementation of E-prescriptions in Hospitals and Other Healthcare Services
    • 3.3. Market Challenges
      • 3.3.1. Regulatory Hurdles Related to ePharmacy
      • 3.3.2. Lack of Cold Chain Logistic Services
    • 3.4. Market Trends
      • 3.4.1. Increasing Demand for Healthcare Products & Services
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Asia Pacific ePharmacy, by Type, Drug Type, Mode of Use and Region (value and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Asia Pacific ePharmacy (Value)
      • 5.2.1. Asia Pacific ePharmacy by: Type (Value)
        • 5.2.1.1. Skin Care
        • 5.2.1.2. Dental
        • 5.2.1.3. Cold and Flu
        • 5.2.1.4. Vitamins
        • 5.2.1.5. Weight Loss
        • 5.2.1.6. Other
      • 5.2.2. Asia Pacific ePharmacy by: Drug Type (Value)
        • 5.2.2.1. Prescription Drugs
        • 5.2.2.2. Over-The-Counter (OTC) Drugs
      • 5.2.3. Asia Pacific ePharmacy by: Mode of Use (Value)
        • 5.2.3.1. Mobile Applications
        • 5.2.3.2. Webpage Based
      • 5.2.4. Asia Pacific ePharmacy Region
        • 5.2.4.1. Asia Pacific
          • 5.2.4.1.1. China
          • 5.2.4.1.2. Japan
          • 5.2.4.1.3. India
          • 5.2.4.1.4. South Korea
          • 5.2.4.1.5. Taiwan
          • 5.2.4.1.6. Australia
          • 5.2.4.1.7. Rest of Asia-Pacific
    • 5.3. Asia Pacific ePharmacy (Price)
      • 5.3.1. Asia Pacific ePharmacy by: Type (Price)
  • 6. ePharmacy: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Netmeds.com (India)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. 1mg (India)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Apollo Pharmacy (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. BestKenko (Japan)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Healthkart (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. PharmEasy (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. EPharmacy.com.au (Australia)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. MyraMed (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Pharmacy Online (Australia)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Metapharmacy.in (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Asia Pacific ePharmacy Sale, by Type, Drug Type, Mode of Use and Region (value and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Asia Pacific ePharmacy (Value)
      • 7.2.1. Asia Pacific ePharmacy by: Type (Value)
        • 7.2.1.1. Skin Care
        • 7.2.1.2. Dental
        • 7.2.1.3. Cold and Flu
        • 7.2.1.4. Vitamins
        • 7.2.1.5. Weight Loss
        • 7.2.1.6. Other
      • 7.2.2. Asia Pacific ePharmacy by: Drug Type (Value)
        • 7.2.2.1. Prescription Drugs
        • 7.2.2.2. Over-The-Counter (OTC) Drugs
      • 7.2.3. Asia Pacific ePharmacy by: Mode of Use (Value)
        • 7.2.3.1. Mobile Applications
        • 7.2.3.2. Webpage Based
      • 7.2.4. Asia Pacific ePharmacy Region
        • 7.2.4.1. Asia Pacific
          • 7.2.4.1.1. China
          • 7.2.4.1.2. Japan
          • 7.2.4.1.3. India
          • 7.2.4.1.4. South Korea
          • 7.2.4.1.5. Taiwan
          • 7.2.4.1.6. Australia
          • 7.2.4.1.7. Rest of Asia-Pacific
    • 7.3. Asia Pacific ePharmacy (Price)
      • 7.3.1. Asia Pacific ePharmacy by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. ePharmacy: by Type(USD Million)
  • Table 2. ePharmacy Skin Care , by Region USD Million (2013-2018)
  • Table 3. ePharmacy Dental , by Region USD Million (2013-2018)
  • Table 4. ePharmacy Cold and Flu , by Region USD Million (2013-2018)
  • Table 5. ePharmacy Vitamins , by Region USD Million (2013-2018)
  • Table 6. ePharmacy Weight Loss , by Region USD Million (2013-2018)
  • Table 7. ePharmacy Other , by Region USD Million (2013-2018)
  • Table 8. ePharmacy: by Drug Type(USD Million)
  • Table 9. ePharmacy Prescription Drugs , by Region USD Million (2013-2018)
  • Table 10. ePharmacy Over-The-Counter (OTC) Drugs , by Region USD Million (2013-2018)
  • Table 11. ePharmacy: by Mode of Use(USD Million)
  • Table 12. ePharmacy Mobile Applications , by Region USD Million (2013-2018)
  • Table 13. ePharmacy Webpage Based , by Region USD Million (2013-2018)
  • Table 14. Asia Pacific ePharmacy, by Country USD Million (2013-2018)
  • Table 15. Asia Pacific ePharmacy, by Type USD Million (2013-2018)
  • Table 16. Asia Pacific ePharmacy, by Drug Type USD Million (2013-2018)
  • Table 17. Asia Pacific ePharmacy, by Mode of Use USD Million (2013-2018)
  • Table 18. China ePharmacy, by Type USD Million (2013-2018)
  • Table 19. China ePharmacy, by Drug Type USD Million (2013-2018)
  • Table 20. China ePharmacy, by Mode of Use USD Million (2013-2018)
  • Table 21. Japan ePharmacy, by Type USD Million (2013-2018)
  • Table 22. Japan ePharmacy, by Drug Type USD Million (2013-2018)
  • Table 23. Japan ePharmacy, by Mode of Use USD Million (2013-2018)
  • Table 24. India ePharmacy, by Type USD Million (2013-2018)
  • Table 25. India ePharmacy, by Drug Type USD Million (2013-2018)
  • Table 26. India ePharmacy, by Mode of Use USD Million (2013-2018)
  • Table 27. South Korea ePharmacy, by Type USD Million (2013-2018)
  • Table 28. South Korea ePharmacy, by Drug Type USD Million (2013-2018)
  • Table 29. South Korea ePharmacy, by Mode of Use USD Million (2013-2018)
  • Table 30. Taiwan ePharmacy, by Type USD Million (2013-2018)
  • Table 31. Taiwan ePharmacy, by Drug Type USD Million (2013-2018)
  • Table 32. Taiwan ePharmacy, by Mode of Use USD Million (2013-2018)
  • Table 33. Australia ePharmacy, by Type USD Million (2013-2018)
  • Table 34. Australia ePharmacy, by Drug Type USD Million (2013-2018)
  • Table 35. Australia ePharmacy, by Mode of Use USD Million (2013-2018)
  • Table 36. Rest of Asia-Pacific ePharmacy, by Type USD Million (2013-2018)
  • Table 37. Rest of Asia-Pacific ePharmacy, by Drug Type USD Million (2013-2018)
  • Table 38. Rest of Asia-Pacific ePharmacy, by Mode of Use USD Million (2013-2018)
  • Table 39. ePharmacy: by Type(USD/Units)
  • Table 40. Company Basic Information, Sales Area and Its Competitors
  • Table 41. Company Basic Information, Sales Area and Its Competitors
  • Table 42. Company Basic Information, Sales Area and Its Competitors
  • Table 43. Company Basic Information, Sales Area and Its Competitors
  • Table 44. Company Basic Information, Sales Area and Its Competitors
  • Table 45. Company Basic Information, Sales Area and Its Competitors
  • Table 46. Company Basic Information, Sales Area and Its Competitors
  • Table 47. Company Basic Information, Sales Area and Its Competitors
  • Table 48. Company Basic Information, Sales Area and Its Competitors
  • Table 49. Company Basic Information, Sales Area and Its Competitors
  • Table 50. ePharmacy: by Type(USD Million)
  • Table 51. ePharmacy Skin Care , by Region USD Million (2019-2024)
  • Table 52. ePharmacy Dental , by Region USD Million (2019-2024)
  • Table 53. ePharmacy Cold and Flu , by Region USD Million (2019-2024)
  • Table 54. ePharmacy Vitamins , by Region USD Million (2019-2024)
  • Table 55. ePharmacy Weight Loss , by Region USD Million (2019-2024)
  • Table 56. ePharmacy Other , by Region USD Million (2019-2024)
  • Table 57. ePharmacy: by Drug Type(USD Million)
  • Table 58. ePharmacy Prescription Drugs , by Region USD Million (2019-2024)
  • Table 59. ePharmacy Over-The-Counter (OTC) Drugs , by Region USD Million (2019-2024)
  • Table 60. ePharmacy: by Mode of Use(USD Million)
  • Table 61. ePharmacy Mobile Applications , by Region USD Million (2019-2024)
  • Table 62. ePharmacy Webpage Based , by Region USD Million (2019-2024)
  • Table 63. Asia Pacific ePharmacy, by Country USD Million (2019-2024)
  • Table 64. Asia Pacific ePharmacy, by Type USD Million (2019-2024)
  • Table 65. Asia Pacific ePharmacy, by Drug Type USD Million (2019-2024)
  • Table 66. Asia Pacific ePharmacy, by Mode of Use USD Million (2019-2024)
  • Table 67. China ePharmacy, by Type USD Million (2019-2024)
  • Table 68. China ePharmacy, by Drug Type USD Million (2019-2024)
  • Table 69. China ePharmacy, by Mode of Use USD Million (2019-2024)
  • Table 70. Japan ePharmacy, by Type USD Million (2019-2024)
  • Table 71. Japan ePharmacy, by Drug Type USD Million (2019-2024)
  • Table 72. Japan ePharmacy, by Mode of Use USD Million (2019-2024)
  • Table 73. India ePharmacy, by Type USD Million (2019-2024)
  • Table 74. India ePharmacy, by Drug Type USD Million (2019-2024)
  • Table 75. India ePharmacy, by Mode of Use USD Million (2019-2024)
  • Table 76. South Korea ePharmacy, by Type USD Million (2019-2024)
  • Table 77. South Korea ePharmacy, by Drug Type USD Million (2019-2024)
  • Table 78. South Korea ePharmacy, by Mode of Use USD Million (2019-2024)
  • Table 79. Taiwan ePharmacy, by Type USD Million (2019-2024)
  • Table 80. Taiwan ePharmacy, by Drug Type USD Million (2019-2024)
  • Table 81. Taiwan ePharmacy, by Mode of Use USD Million (2019-2024)
  • Table 82. Australia ePharmacy, by Type USD Million (2019-2024)
  • Table 83. Australia ePharmacy, by Drug Type USD Million (2019-2024)
  • Table 84. Australia ePharmacy, by Mode of Use USD Million (2019-2024)
  • Table 85. Rest of Asia-Pacific ePharmacy, by Type USD Million (2019-2024)
  • Table 86. Rest of Asia-Pacific ePharmacy, by Drug Type USD Million (2019-2024)
  • Table 87. Rest of Asia-Pacific ePharmacy, by Mode of Use USD Million (2019-2024)
  • Table 88. ePharmacy: by Type(USD/Units)
  • Table 89. Research Programs/Design for This Report
  • Table 90. Key Data Information from Secondary Sources
  • Table 91. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Asia Pacific ePharmacy: by Type USD Million (2013-2018)
  • Figure 5. Asia Pacific ePharmacy: by Drug Type USD Million (2013-2018)
  • Figure 6. Asia Pacific ePharmacy: by Mode of Use USD Million (2013-2018)
  • Figure 7. Asia Pacific ePharmacy Share (%), by Country
  • Figure 8. Asia Pacific ePharmacy: by Type USD/Units (2013-2018)
  • Figure 9. Asia Pacific ePharmacy share by Players 2018 (%)
  • Figure 10. Asia Pacific ePharmacy share by Players (Top 3) 2018(%)
  • Figure 11. Asia Pacific ePharmacy share by Players (Top 5) 2018(%)
  • Figure 12. BCG Matrix for key Companies
  • Figure 13. Netmeds.com (India) Revenue, Net Income and Gross profit
  • Figure 14. Netmeds.com (India) Revenue: by Geography 2018
  • Figure 15. 1mg (India) Revenue, Net Income and Gross profit
  • Figure 16. 1mg (India) Revenue: by Geography 2018
  • Figure 17. Apollo Pharmacy (India) Revenue, Net Income and Gross profit
  • Figure 18. Apollo Pharmacy (India) Revenue: by Geography 2018
  • Figure 19. BestKenko (Japan) Revenue, Net Income and Gross profit
  • Figure 20. BestKenko (Japan) Revenue: by Geography 2018
  • Figure 21. Healthkart (India) Revenue, Net Income and Gross profit
  • Figure 22. Healthkart (India) Revenue: by Geography 2018
  • Figure 23. PharmEasy (India) Revenue, Net Income and Gross profit
  • Figure 24. PharmEasy (India) Revenue: by Geography 2018
  • Figure 25. EPharmacy.com.au (Australia) Revenue, Net Income and Gross profit
  • Figure 26. EPharmacy.com.au (Australia) Revenue: by Geography 2018
  • Figure 27. MyraMed (India) Revenue, Net Income and Gross profit
  • Figure 28. MyraMed (India) Revenue: by Geography 2018
  • Figure 29. Pharmacy Online (Australia) Revenue, Net Income and Gross profit
  • Figure 30. Pharmacy Online (Australia) Revenue: by Geography 2018
  • Figure 31. Metapharmacy.in (India) Revenue, Net Income and Gross profit
  • Figure 32. Metapharmacy.in (India) Revenue: by Geography 2018
  • Figure 33. Asia Pacific ePharmacy: by Type USD Million (2019-2024)
  • Figure 34. Asia Pacific ePharmacy: by Drug Type USD Million (2019-2024)
  • Figure 35. Asia Pacific ePharmacy: by Mode of Use USD Million (2019-2024)
  • Figure 36. Asia Pacific ePharmacy Share (%), by Country
  • Figure 37. Asia Pacific ePharmacy: by Type USD/Units (2019-2024)
Some of the key companies/manufacturers profiled in the report
  • Netmeds.com (India)
  • 1mg (India)
  • Apollo Pharmacy (India)
  • BestKenko (Japan)
  • Healthkart (India)
  • PharmEasy (India)
  • ePharmacy.com.au (Australia)
  • MyraMed (India)
  • Pharmacy Online (Australia)
  • Metapharmacy.in (India)
Additional players considered in the study are as follows:
Medplusmart (India) , mChemist (India) , Medidart.com (India) , MedsonWay (India)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation